← Eichor · All briefs

NCT07723248 — Metastatic Castration Resistant Prostate Cancer trial site landscape

Public-registry site landscape for NCT07723248, a Metastatic Castration Resistant Prostate Cancer study sponsored by ORIC Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT07723248 (registry record)
SponsorORIC Pharmaceuticals
Condition(s)Metastatic Castration Resistant Prostate Cancer
PhasePHASE3
Listed sites2
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07723248 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.